{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "16192672", "DateCompleted": {"Year": "2006", "Month": "01", "Day": "20"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0962-9351", "JournalIssue": {"Volume": "2005", "Issue": "4", "PubDate": {"Year": "2005", "Month": "Aug", "Day": "31"}}, "Title": "Mediators of inflammation", "ISOAbbreviation": "Mediators Inflamm"}, "ArticleTitle": "Ozone therapy on rats submitted to subtotal nephrectomy: role of antioxidant system.", "Pagination": {"StartPage": "221", "EndPage": "227", "MedlinePgn": "221-7"}, "Abstract": {"AbstractText": ["Chronic renal failure (CRF) represents a world health problem. Ozone increases the endogenous antioxidant defense system, preserving the cell redox state. The aim of this study is to evaluate the effect of ozone/oxygen mixture in the renal function, morphology, and biochemical parameters, in an experimental model of CRF (subtotal nephrectomy). Ozone/oxygen mixture was applied daily, by rectal insufflation (0.5 mg/kg) for 15 sessions after the nephrectomy. Renal function was evaluated, as well as different biochemical parameters, at the beginning and at the end of the study (10 weeks). Renal plasmatic flow (RPF), glomerular filtration rate (GFR), the urine excretion index, and the sodium and potassium excretions (as a measurement of tubular function) in the ozone group were similar to those in Sham group. Nevertheless, nephrectomized rats without ozone (positive control group) showed the lowest RPF, GFR, and urine excretion figures, as well as tubular function. Animals treated with ozone showed systolic arterial pressure (SAP) figures lower than those in the positive control group, but higher values compared to Sham group. Serum creatinine values and protein excretion in 24 hours in the ozone group were decreased compared with nephrectomized rats, but were still higher than normal values. Histological study demonstrated that animals treated with ozone showed less number of lesions in comparison with nephrectomized rats. Thiobarbituric acid reactive substances were significantly increased in nephrectomized and ozone-treated nephrectomized rats in comparison with Sham group. In the positive control group, superoxide dismutase (SOD) and catalase (CAT) showed the lowest figures in comparison with the other groups. However, ozone/oxygen mixture induced a significant stimulation in the enzymatic activity of CAT, SOD, and glutathione peroxidase, as well as reduced glutathione in relation with Sham and positive control groups. In this animal model of CRF, ozone rectal administrations produced a delay in the advance of the disease, protecting the kidneys against vascular, hemorheological, and oxidative mechanisms. This behavior suggests ozone therapy has a protective effect on renal tissue by downregulation of the oxidative stress shown in CRF."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedicine, Ozone Research Center, National Center for Scientific Research, Cuba."}], "Identifier": [], "LastName": "Calunga", "ForeName": "Jos\u00e9 Luis", "Initials": "JL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zamora", "ForeName": "Zullyt B", "Initials": "ZB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Borrego", "ForeName": "Aluet", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "R\u00edo", "ForeName": "Sarah\u00ed del", "Initials": "Sd"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Barber", "ForeName": "Ernesto", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Men\u00e9ndez", "ForeName": "Silvia", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hern\u00e1ndez", "ForeName": "Frank", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Montero", "ForeName": "Teresita", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Taboada", "ForeName": "Dunia", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mediators Inflamm", "NlmUniqueID": "9209001", "ISSNLinking": "0962-9351"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9NEZ333N27", "NameOfSubstance": "Sodium"}, {"RegistryNumber": "RWP5GA015D", "NameOfSubstance": "Potassium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Glomerular Filtration Rate"}, {"QualifierName": ["blood supply", "metabolism"], "DescriptorName": "Kidney"}, {"QualifierName": ["drug therapy", "physiopathology", "urine"], "DescriptorName": "Kidney Failure, Chronic"}, {"QualifierName": [], "DescriptorName": "Models, Animal"}, {"QualifierName": [], "DescriptorName": "Nephrectomy"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ozone"}, {"QualifierName": ["urine"], "DescriptorName": "Potassium"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["urine"], "DescriptorName": "Sodium"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Fauci AS, Braunwald E, Isselbacher KJ, et al. Chronic renal failure. In: Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill; 1998. pp. 1513\u20131520."}, {"Citation": "Lane PH. Long-term furosemide treatment in the normal rat: dissociation of glomerular hypertrophy and glomerulosclerosis. Am J Kidney Dis. 1999;33(6):1058\u20131063.", "ArticleIdList": ["10352193"]}, {"Citation": "Fine LG. Adaptation of renal tubule in uremia. Kidney Int. 1982;22(5):546\u2013549.", "ArticleIdList": ["6759761"]}, {"Citation": "Slomowitz L. Tubuloglomerular feedback in chronic renal failure. Nephron. 1987;45(4):264\u2013271.", "ArticleIdList": ["3295572"]}, {"Citation": "Sheldin DW, Gusbech G. The kidney physiology and physiopathology. In: Roven Press., editor. The Kidney Physiology and Physiopathology. New York, NY: Roven Press; 1985. pp. 1901\u20131905."}, {"Citation": "Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: their regulation and function. Kidney Int. 1994;45(1):1\u20139.", "ArticleIdList": ["8126996"]}, {"Citation": "Yoshioka T, Ichikawa I. Glomerular dysfunction induced by polymorphonuclear leukocyte-derived reactive oxygen species. Am J Physiol. 1989;257(pt 2):F53\u2013F59.", "ArticleIdList": ["2750924"]}, {"Citation": "Yoshioka T, Moore-Jarret T, Ichikawa I, Yared A. Reactive oxygen species of extra-renal origin can induce massive functional proteinuria. Kidney Int. 1990;37:497\u2013502."}, {"Citation": "Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int. 1991;40(2):291\u2013301.", "ArticleIdList": ["1942778"]}, {"Citation": "Yoshioka T, Bills T, Moore-Jarrett T, Greene HL, Burr IM, Ichikawa I. Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int. 1990;38(2):282\u2013288.", "ArticleIdList": ["2402119"]}, {"Citation": "Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int. 2003;63(1):179\u2013185.", "ArticleIdList": ["12472781"]}, {"Citation": "Szolkiewicz M, Nieweglowski T, Korczynska J, et al. Upregulation of fatty acid synthase gene expression in experimental chronic renal failure. Metabolism. 2002;51(12):1605\u20131610.", "ArticleIdList": ["12489075"]}, {"Citation": "Matsuno K, Miura T, Shinriki N. In: Proceedings of the 13th Ozone World Congress. Vol 3. Scottsdale, Ariz: Internaional Ozone Association; 1997. The effect of ozone on platelet activation; pp. 178\u2013184."}, {"Citation": "Bocci V. Ozone as a bioregulator: pharmacology and toxicology of ozonetherapy today. J Biol Regul Homeost Agents. 1996;10(2-3):31\u201353.", "ArticleIdList": ["9250885"]}, {"Citation": "Barber E, Men\u00e9ndez S, Le\u00f3n OS, et al. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediators Inflamm. 1999;8(1):37\u201341.", "ArticleIdList": ["PMC1781776", "10704088"]}, {"Citation": "Hern\u00e1ndez F, Men\u00e9ndez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med. 1995;19(1):115\u2013119.", "ArticleIdList": ["7635353"]}, {"Citation": "Le\u00f3n OS, Men\u00e9ndez S, Merino N, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm. 1998;7(4):289\u2013294.", "ArticleIdList": ["PMC1781855", "9792340"]}, {"Citation": "Peralta C, Le\u00f3n OS, Xaus C, et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res. 1999;31(3):191\u2013196.", "ArticleIdList": ["10499775"]}, {"Citation": "Candelario-Jalil E, Mohammed-Al-Dalain S, Le\u00f3n OS, Men\u00e9ndez S, P\u00e9rez-Davidson G, Merino N. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol. 2001;21(4):297\u2013301.", "ArticleIdList": ["11481663"]}, {"Citation": "Ajamieh H, Merino N, Candelario-Jalil E, et al. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res. 2002;45(4):333\u2013339.", "ArticleIdList": ["12030798"]}, {"Citation": "Al-Dalain SM, Mart\u00ednez G, Candelario-Jalil E, et al. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res. 2001;44(5):391\u2013396.", "ArticleIdList": ["11712870"]}, {"Citation": "Ajamieh HH, Men\u00e9ndez S, Mart\u00ednez-S\u00e1nchez G, et al. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 2004;24(1):55\u201362.", "ArticleIdList": ["15102001"]}, {"Citation": "Ajamieh HH, Berlanga J, Merino N, et al. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int. 2005;18(5):604\u2013612.", "ArticleIdList": ["15819811"]}, {"Citation": "Al-Dalain SM, Mart\u00ednez G, Men\u00e9ndez S, et al. Therapeutic efficacy of ozone medical treatments in patients with diabetic foot. Eur J Pharmacol. In press.", "ArticleIdList": ["16198334"]}, {"Citation": "Zamora Z, Borrego A, L\u00f3pez O, et al. Effects of ozone oxidative preconditioning on TNF-\u03b1 release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005;2005(1):16\u201322.", "ArticleIdList": ["PMC1482874", "15770062"]}, {"Citation": "Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76(2):612\u2013619.", "ArticleIdList": ["PMC423867", "2993362"]}, {"Citation": "Folin O. A system of blood analysis. J Biol Chem. 1949;38:81\u201385."}, {"Citation": "Smith HW, Tinkelstein N. The renal clearance of substituted hipuric acid derivatives and other aromatic acids in dog and man. J Clin Invest. 1945;24:388\u2013391.", "ArticleIdList": ["PMC435470", "16695228"]}, {"Citation": "Schreiner GE. Determination of inulin by means of resorcinol. Proc Soc Exp Biol Med. 1950;74(1):117\u2013120.", "ArticleIdList": ["15430407"]}, {"Citation": "Jamison RL, Maffly RH. The urinary concentrating mechanism. N Engl J Med. 1976;295(19):1059\u20131067.", "ArticleIdList": ["972660"]}, {"Citation": "Oser BL. Determination of sodium and potassium. In: Hawk's, editor. Physiological Chemistry. New York, NY: MacGraw-Hill; 1965. pp. 1140\u20131145."}, {"Citation": "Oser BL. Biuret test for protein determination. In: Hawk's, editor. Physiological Chemistry. New York, NY: MacGraw-Hill; 1965. pp. 179\u2013184."}, {"Citation": "Brot J. The renal clearance endogenous creatinine in man. J Clin Invest. 1948;27:645\u201354.", "ArticleIdList": ["PMC439537", "16695585"]}, {"Citation": "Beutler E, Duron O, Mikus B. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;16:882\u2013888.", "ArticleIdList": ["13967893"]}, {"Citation": "Minami M, Yoshikawa H. A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta. 1979;92(3):337\u2013342.", "ArticleIdList": ["436274"]}, {"Citation": "Evans C, Diplock AT. Techniques in free radical research. In: Burtin RH, Knippenberg PH, editors. Laboratory Techniques in Biochemistry and Molecular Biology. Amsterdam, The Netherlands: Elsevier; 1991. pp. 199\u2013206."}, {"Citation": "Faraji B, Kang HK, Valentine JL. Methods compared for determining glutathione peroxidase activity in blood. Clin Chem. 1987;33(4):539\u2013543.", "ArticleIdList": ["3829387"]}, {"Citation": "Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351\u2013358.", "ArticleIdList": ["36810"]}, {"Citation": "Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265\u2013275.", "ArticleIdList": ["14907713"]}, {"Citation": "Mezzano SA, Droguett M, Burgos ME, et al. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. J Kidney Int. 2000;57(1):147\u2013158.", "ArticleIdList": ["10620196"]}, {"Citation": "Hansch GM, Wagner C, Burger A, Dong W, Staehler G, Stoeck M. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J Cell Physiol. 1995;163(3):451\u2013457.", "ArticleIdList": ["7775588"]}, {"Citation": "Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998;53(4):853\u2013861.", "ArticleIdList": ["9551391"]}, {"Citation": "Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int. 1998;53(suppl 65):S74\u2013S77.", "ArticleIdList": ["9551436"]}, {"Citation": "Le\u00f3n OS, Men\u00e9ndez S, Merino N, et al. Influencia del precondicionamiento oxidativo con ozono sobre los niveles de calcio. Revista CENIC Ciencias Biol\u00f3gicas. 1998;29(3):134\u2013136."}]}], "History": [{"Year": "2005", "Month": "9", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "1", "Day": "21", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "9", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "8", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16192672", "PMC1526476", "10.1155/MI.2005.221", "S0962935105506057"]}}], "PubmedBookArticle": []}